ROLES OF μ-OPIOID RECEPTORS IN DEVELOPMENT OF TOLERANCE TO DIISOPROPYLFLUOROPHOSPHATE (DFP)
スポンサーリンク
概要
- 論文の詳細を見る
Anatomical evidence indicates that cholinergic and opioidergic systems are co-localized and acting on the same neuron. However, the regulatory mechanisms between cholinergic and opioidergic system have not been well characterized. In the present study, the potential involvement of μ-opioid receptors in mediating the changes of toxic signs and muscarinic receptor binding after administration of irreversible anti-acetylcholinesterase diisopropylfluorophosphate (DFP) was investigated. DFP (1 mg/kg/day, subcutaneous injection, s.c.)-induced tremors and chewing movements were monitored during the 28-day treatment period in μ-opioid receptor knockout and wild type mice. Autoradiographic studies of total, M1, and M2 muscarinic receptors were conducted using [^3H]-quinuclidinyl benzilate, [^3H]-pirenzepine, and [^3H]-AF-DX384 as ligands, respectively. DFP-induced tremors in both μ-opioid receptor knockout and wild type mice showed tolerance development. However, DFP-induced tremors in μ-opioid receptor knockout mice showed delayed tolerance development than that of DFP-treated wild type controls. DFP-induced chewing movements in both μ-opioid receptor knockout and wild type mice failed to show development of tolerance after four weeks of treatment. M2 muscarinic receptor binding of DFP-treated μ-opioid receptor knockout mice was significantly decreased than that of the DFP-treated wild type controls in the striatum, but not in the cortex and hippocampus. However, there were no significant differences in total and M1 muscarinic receptor binding between DFP-treated μ-opioid receptor knockout and wild type mice in the cortex, striatum and hippocampus. These studies indicate that μ-opioid receptors play an important role through the striatal M2 muscarinic receptors to regulate the development of tolerance to DFP-induced tremors.
- 日本トキシコロジー学会の論文
- 2005-02-25
著者
-
HO Ing
Department of Pharmacology and Toxicology, University of Mississippi Medical Center
-
LOH Horace
Department of Pharmacology, University of Minnesota Medical School
-
Ho Ing
Department Of Pharmacology & Toxicology University Of Mississippi Medical Center
-
Ho Ing
Department Of Pharmacology And Toxicology University Of Mississippi Medical Center
-
Loh H
Department Of Pharmacology University Of Minnesota Medical School
-
Loh Horace
Department Of Pharmacology University Of Minnesota Medical School
-
MA Tangeng
Department of Pharmacology and Toxicology, University of Mississippi Medical Center
-
TIEN Lu
Department of Pharmacology and Toxicology, University of Mississippi Medical Center
-
FAN Lir
Department of Pharmacology and Toxicology, University of Mississippi Medical Center
-
FAN Lir-Wan
Department of Pharmacology & Toxicology, University of Mississippi Medical Center
-
Ma Tangeng
Department Of Pharmacology And Toxicology University Of Mississippi Medical Center
-
Tien Lu
Department Of Pharmacology And Toxicology University Of Mississippi Medical Center
-
Fan Lir-wan
Dep. Of Pharmacology & Toxicology Univ. Of Mississippi Medical Center
-
Tien Lu-Tai
Department of Pharmacology and Toxicology, University of Mississippi Medical Center
関連論文
- Possible Existence of a Novel Receptor for Uridine Analogues in the Central Nervous System Using Two Isomers, N^3-(S)-(+)-and N^3-(R)-(-)-α-Hydroxy-β-phenethyluridines
- Hypnotic Action of N^3-Substituted Arabinofuranosyluracils on Mice
- Synthesis and Central Nervous System Depressant Effects of N^3-Substituted 2', 3'-O-Isopropylideneuridines
- Pharmacologica Efects in Mice of Anandamide and Its Related Fatty Acid Ethanolamides, and Enhancement of Cataleptogenic Effect of Anandamide by Phenylmethylsulfonyl Fluoride
- Compertitive Inhibition of Δ^8-Tetrahydrocannabinol and Its Active Metabolites for Cannabinoid Receptor Binding
- Lack of μ-Opioid Receptor-Mediated G-Protein Activation in the Spinal Cord of Mice Lacking Exon 1 or Exons 2 and 3 of the MOR-1 Gene
- 田邊賞を受賞して(日本トキシコロジー学会からのお知らせ)
- STRUCTURE-ACTIVITY RELATIONSHIP OF URIDINE DERIVATIVES FOR HYPNOTIC ACTIVITY
- Potentiating Effects of N^1,N^3-Diallyluracil, N^1,N^3-Diallylthymine and N^1,N^3-Diallyl-6-methyluracil on Pentobarbital-Induced Sleep and Diazepam-Induced Motor Incoordination(Pharmacological,Chemical)
- Potentiation of Barbiturate-Induced Narcosis by N,N'-(or N,S-) Diallyl-Substituted Derivatives of Phenobarbital, Amobarbital and Thiopental in Mice(Pharmacological)
- EXCITATORY AMINO ACIDS AND LEAD-INDUCED NEUROTOXICITY
- ROLES OF μ-OPIOID RECEPTORS IN DEVELOPMENT OF TOLERANCE TO DIISOPROPYLFLUOROPHOSPHATE (DFP)
- DIFFERENTIAL MODULATION OF MUSCARINIC RECEPTORS IN THE RAT BRAIN BY REPEATED EXPOSURE TO METHYL PARATHION
- MECHANISM OF TOLERANCE DEVELOPMENT TO PHENCYCLIDINE IN RELATION TO GABA-ERGIC NEURONAL AND DISPOSITIONAL FUNCTIONS IN MICE
- Nonspecific Effects of the Selective κ-Opioid Receptor Agonist U-50, 488H on Dopamine Uptake and Release in PC12 Cells
- Butorphanol : Effects of a Prototypical Agonist-Antagonist Analgesic on κ-Opioid Receptors
- The Role of Glutamate in Physical Dependence on Opioids
- Effects of Barbiturates on GABA System: Comparison to Alcohol and Benzodiazepines.